Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study

BMJ Qual Saf. 2020 Jan;29(1):41-51. doi: 10.1136/bmjqs-2019-009545. Epub 2019 Aug 8.

Abstract

Background: In-hospital medication review has been linked to improved outcomes after discharge, yet there is little evidence to support the use of community pharmacy-based interventions as part of transitional care.

Objective: To determine whether receipt of a postdischarge community pharmacy-based medication reconciliation and adherence review is associated with a reduced risk of death or re-admission.

Design: Propensity score-matched cohort study.

Setting: Ontario, Canada PARTICIPANTS: Patients over age 66 years discharged home from an acute care hospital from 1 April 2007 to 16 September 2016.

Exposure: MedsCheck, a publicly funded medication reconciliation and adherence review provided by community pharmacists.

Main outcome: The primary outcome was time to death or re-admission (defined as an emergency department visit or urgent rehospitalisation) up to 30 days. Secondary outcomes were the 30-day count of outpatient physician visits and time to adverse drug event.

Results: MedsCheck recipients had a lower risk of 30-day death or re-admission (23.4% vs 23.9%, HR 0.97, 95% CI 0.95 to 1.00, p=0.02), driven by a decreased risk of death (1.7% vs 2.1%, HR 0.79, 95% CI 0.73 to 0.86) and rehospitalisation (11.0% vs 11.4%, HR 0.96, 95% 0.93-0.99). In a post hoc sensitivity analysis with pharmacy random effects added to the propensity score model, these results were substantially attenuated. There was no significant difference in 30-day return to the emergency department (22.5% vs 22.8%, HR 0.99, 95% CI 0.96 to 1.01) or adverse drug events (1.5% vs 1.5%, HR 1.03, 95% CI 0.94 to 1.12). MedsCheck recipients had more outpatient visits (mean 2.11 vs 2.09, RR 1.01, 95% CI 1.00 to 1.02, p=0.02).

Conclusions and relevance: Among older adults, receipt of a community pharmacy-based medication reconciliation and adherence review was associated with a small reduced risk of short-term death or re-admission. Due to the possibility of unmeasured confounding, experimental studies are needed to clarify the relationship between postdischarge community pharmacy-based medication review and patient outcomes.

Keywords: medication reconciliation; medication safety; transitions in care.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Community Pharmacy Services / statistics & numerical data*
  • Comorbidity
  • Female
  • Heart Failure / drug therapy
  • Heart Failure / mortality*
  • Humans
  • Male
  • Medication Adherence / statistics & numerical data
  • Medication Reconciliation / statistics & numerical data*
  • Ontario
  • Patient Discharge / statistics & numerical data*
  • Patient Readmission / statistics & numerical data*
  • Propensity Score
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / mortality*
  • Residence Characteristics
  • Retrospective Studies
  • Socioeconomic Factors

Grants and funding